Although Wal-Mart Stores Inc. (NYSE: WMT) gave up the fight to run an internal banking operation that would have saved the company millions in transaction and other costs, the retailer's true intentions may yet be coming through after all. The company's recent Visa debit card announcement makes me think that Wal-Mart, darn it, will get in the banking business for consumers some how, some way. It just won't be an FDIC-insured banking institution.
Does Wal-Mart want to take a piece of the $36 billion first-quarter profit that the banking industry saw (fourth highest total ever)? Why would it not? The finance industry is so incredibly profitable that any retailer with the scale of Wal-Mart (huge, but with margins that aren't that huge) would be dumb not to look at new ways to generate profit growth. Who better than the world's largest retailer where customers come to in drives 24 hours a day?
Well, that notion doesn't sit right with the U.S. banking industry (nor should it), which fears the "commoditization of banking" if Wal-Mart enters the personal banking domain. What else is new? Wal-Mart has moved into many industries to toss out competition in price, only to find that "what goes around comes around" as customers now are increasingly seeking nicer alternatives with more value-added than what Wal-Mart can provide. Should the banking industry be worried? As long as the banking industry continues to innovate, Wal-Mart will prove to be little threat. Well, at least initially.
Last updated: February 13, 2012: 08:18 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
TheFlyOnTheWall.com Headlines
- Symantec management to meet with UBS
- Boeing: Dreamliner glitch won't slow production, CNBC reports
- NetApp downgraded to Hold from Buy at ThinkEquity
- Pricing for ultrabooks won't hit 'sweet spot' until 2013, DigiTimes says
- EQT Corporation subsidiary files registration statement
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

